Springer Files 13D for Tectonic Therapeutic

TL;DR

**Springer takes a big stake in Tectonic!**

AI Summary

On June 20, 2024, Timothy A. Springer filed a Schedule 13D for Tectonic Therapeutic, Inc. (formerly AvroBio, Inc.). The filing indicates a change in beneficial ownership, with Springer now holding a significant stake in the company. The specific number of shares and percentage of ownership are detailed within the filing.

Why It Matters

This filing signals a significant change in ownership for Tectonic Therapeutic, potentially indicating a new strategic direction or increased investor interest.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or shifts in control, which can introduce volatility.

Key Numbers

• 0001681087 — Central Index Key (Tectonic Therapeutic, Inc. identifier)
• 0001055624 — Central Index Key (Timothy A. Springer identifier)

Key Players & Entities

• Tectonic Therapeutic, Inc. (company) — Subject Company
• Timothy A. Springer (person) — Filing Person
• AvroBio, Inc. (company) — Former Company Name
• Michael K. Bradshaw, Jr. (person) — Authorized Contact
• Nelson Mullins Riley & Scarborough LLP (company) — Legal Counsel

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
• $12.39908 — nic common stock at a purchase price of $12.39908 per share, for an aggregate purchase pr
• $96.6 million — gregate purchase price of approximately $96.6 million. In addition, in connection with the cl
• $130.7 million — nancing and the SAFEs was approximately $130.7 million and the shares of Tectonic common stock
• $16.80 — 11,760 Shares, at an exercise price of $16.80 per share, which will vest as follows:

Filing Documents

• ea0208483-13dspringer_tect.htm (SC 13D) — 74KB
• ea020848301ex99-3_tect.htm (EX-99.3) — 4KB
• 0001213900-24-055917.txt ( ) — 79KB

Purpose of Transaction

Item 4. Purpose of Transaction Agreement and Plan of Merger and Reorganization On June 20, 2024, the Delaware corporation formerly known as “AVROBIO, Inc.” completed its previously announced merger transaction in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of January 30, 2024 (the “Merger Agreement”) by and among AVROBIO, Inc. (“AVROBIO”), Tectonic Therapeutic, Inc. (“Tectonic”), and Alpine Merger Subsidiary, Inc., a direct wholly owned subsidiary of AVROBIO (“Merger Sub”), pursuant to which Merger Sub merged with and into Tectonic, with Tectonic surviving as a direct wholly owned subsidiary of AVROBIO and the surviving corporation of the merger (the “Merger”). Additionally, as a result of the Merger, (i) Tectonic changed its name from “Tectonic Therapeutic, Inc.” to “Tectonic Operating Company, Inc.”, and (ii) AVROBIO changed its name from “AVROBIO, Inc.” to “Tectonic Therapeutic, Inc.” (the “Company”). Under the terms of the Merger, immediately prior to the effective time of the Merger, each share of Tectonic’s preferred stock was converted into one share of Tectonic’s common stock. At the effective time of the Merger, the Company issued an aggregate of approximately 5,322,169 shares of its common stock to Tectonic stockholders, based on an exchange ratio of 0.53441999 (after giving effect to a 1-for-12 reverse stock split of its common stock) shares of the Company’s common stock for each share of Tectonic common stock outstanding immediately prior to the Merger, including those shares of common stock issued upon conversion of the Tectonic preferred stock and simple agreements for future equity and those shares of Tectonic common stock issued in the Tectonic pre-closing financing transaction which closed on June 20, 2024, immediately prior to the closing of the Merg

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: June 26, 2024 /s/ Timothy A. Springer Timothy A Springer TAS Partners LLC By: /s/ Timothy A. Springer Name: Timothy A. Springer Title: Manager

View Full Filing

View this SC 13D filing on SEC EDGAR